Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Psychedelic therapy gains ground in Europe, under strict conditions

Summary by Radio France Internationale
Psilocybin, the active compound in hallucinogenic mushrooms, is edging into mainstream psychiatry in parts of Europe – with Switzerland already treating patients and the Czech Republic opening tightly supervised therapies. But France is holding back, limiting its use to clinical trials while doctors wait for stronger evidence of its efficacy.

1 Articles

Radio France InternationaleRadio France Internationale
Center

Psychedelic therapy gains ground in Europe, under strict conditions

Psilocybin, the active compound in hallucinogenic mushrooms, is edging into mainstream psychiatry in parts of Europe – with Switzerland already treating patients and the Czech Republic opening tightly supervised therapies. But France is holding back, limiting its use to clinical trials while doctors wait for stronger evidence of its efficacy.

·Paris, France
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Radio France Internationale broke the news in Paris, France on Friday, January 30, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Psychedelics icon

Psychedelics

Asia icon

Asia

Switzerland icon

Switzerland

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal